Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever?

Erden, A; Batu, ED; Sarı, A; Sönmez, HAFİZE; Armagan, B; Demir, S; Fırat, E; Bilginer, Y; Bilgen, SA; Karadağ, Ö; Kalyoncu, U; Kiraz, S; Ertenli, I; Özen, S; Akdogan, A

Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever?

Atıf İçin Kopyala

Erden A., Batu E., Sarı A., Sönmez H. E., Armagan B., Demir S., ...Daha Fazla

Clinical and experimental rheumatology, cilt.36, ss.97-102, 2018 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 36
Basım Tarihi: 2018
Dergi Adı: Clinical and experimental rheumatology
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.97-102
Kocaeli Üniversitesi Adresli: Evet

Özet

Objective. Colchicine is the main therapy for familial Mediterranean fever (FMF); however, 5-10% of patients are colchicine-resistant. There is no standard and validated definition for colchicine resistance. We aimed to compare the existing definitions for colchicine resistance in both adult and paediatric FMF patients to find out the best definition to determine colchicine-resistant patients.